Related Experiment Videos
Amelioration of chronic anthracycline cardiotoxicity by ICRF-187 and other compounds
1Division of Drug Biology, Food and Drug Administration, Washington, D.C. 20204.
Cancer Treatment Reviews
|December 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity.
Cancer chemotherapy and pharmacology·2001
Cardiovascular effects of buccal exposure to dermal nicotine patches in the dog: a comparative evaluation.
Journal of toxicology. Clinical toxicology·2001
Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats.
Cancer chemotherapy and pharmacology·2001
Specific functional interaction of human cytohesin-1 and ADP-ribosylation factor domain protein (ARD1).
The Journal of biological chemistry·2000
Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex.
Proceedings of the National Academy of Sciences of the United States of America·2000
Reduced oxaliplatin exposure in gastrointestinal cancers: A systematic review and meta-analysis.
Cancer treatment reviews·2026
Optimizing the treatment pathway in post-docetaxel mCRPC: PSMA-RLT vs cabazitaxel.
Cancer treatment reviews·2026
p53 Co-mutations in EGFR-mutant NSCLC: biological insight and therapeutic implications.
Cancer treatment reviews·2026
From drug response to resistance evolution: Leveraging 3D cancer models for functional precision oncology.
Cancer treatment reviews·2026